ClearPoint Neuro, Inc.
CLPT
$17.88
-$0.10-0.56%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.51% | -44.56% | -18.44% | -32.42% | -45.34% |
| Total Depreciation and Amortization | 144.31% | 59.66% | -13.94% | 35.21% | -29.54% |
| Total Amortization of Deferred Charges | -- | -- | 77.27% | 50.00% | -- |
| Total Other Non-Cash Items | 24.61% | 15.10% | 22.90% | 70.10% | 56.48% |
| Change in Net Operating Assets | 14.86% | -519.28% | -102.58% | 214.53% | -69.05% |
| Cash from Operations | -29.08% | -871.84% | -160.30% | 4.35% | -60.73% |
| Capital Expenditure | -252.46% | 81.37% | -1,558.33% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -252.46% | 513.69% | -1,558.33% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 604.76% | 169.42% | -- | 1,150.69% | -99.87% |
| Repurchase of Common Stock | -52.72% | -132.14% | 100.00% | -178.13% | -764.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.46% | 52,775.68% | 100.00% | 19,885.63% | -108.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.51% | 683.53% | 70.55% | 1,269.62% | -163.19% |